Диссертация (1174236), страница 17
Текст из файла (страница 17)
Мустафина //Пульмонология. – 2013. – № 2. – С. 5-9.33.Шевницын Л.С. Пути развития кремнийорганического комплекса ЧПО «Химпром» / Л.С. Шевницын // Доклад на конференции в НИХТЭОС. – 1985.– С. 25.34.Шевницына, О.Ю. Иммуно–физиологическая реакция организма человека вусловиях кремнийорганического производства: автореф. дис. … канд. биол.наук: 03.00.13. / Шевницына Ольга Юрьевна.
– Чебоксары, 2004. – 22 с.35.Яздовский, В.В. HLA и аллергические заболевания / В.В. Яздовский //Пульмонология. – 1994. – № 4. – С. 6-19.36.Янбаева,цитокиновД.Г. / Полиморфные варианты генов провоспалительныхкакмаркерыпредрасположенностикхроническойобструктивной болезни легких / Д.Г. Янбаева, О.Ф. Байнак, Г.Ф. Корытинаи др.
// Пульмонология. – 2005. – № 5. – С.17-22.37.Abbas, A.K. Cellular and Molekular Immunology / A.K. Abbas. – Philadeiphia,London, Toronto, Montreal, Tokyo. – 1995.38.Agusti, A. Persistent systemic inflammation is associated with poor clinicaloutcomes in COPD: a novel phenotype / А. Agusti, L.D. Edwards, S.I. Rennardet al. // PLoS One.
– 2012. – Vol.7. – № 5. – Р. е37483.84.10739.Alif, S. M. Occupational exposure and risk of chronic obstructive pulmonarydisease: a systematic review and meta–analysis / S. M. Alif, S. C. Dharmage,G. Bowatte et al. // Expert Rev. Respir. Med. – 2016. – Vol. 10. – № 8. –Р. 861-872.40.Ameille, J. Occupational chronic obstructive pulmonary disease: a poorlyunderstood disease / J. Ameille, J.C. Dalphin, А.
Descatha, J.C. Pairon // Rev.Mal. Respir. – 2006. – Vol. 23. – № 4. – P. 119-130.41.American Thoracic Society. Adverse effects of crystalline silica exposure. Am.J. Respir. Crit. Care Med. – 1997. –Vol. 155 – Р. 761-765.42.Arbex, M.A. Urban air pollution and chronic obstructive pulmonary diseaserelated emergency department visits / M.A. Arbex, G.M. de Souza Conceicao,S.P.
Cendon et al. // J. Epidemiol Community Health. – 2009. – Vol. 63. – № 10.– Р. 777-783.43.Aschard, H. Evidence for large-scale gene-by-smoking interaction effects onpulmonary function / Н. Aschard, M.D. Tobin, D.B. Hancock et al. // Int. J.Epidemiol. – 2017. – Jan 12.pii: dyw318.44.Bagdonas, E. Novel aspects of pathogenesis and regeneration mechanisms inCOPD / Е. Bagdonas, J. Raudoniute, I. Bruzauskaite, R. Aldonyte // Int. J.
Chron.Obstruct. Pulmon. Dis. – 2015. – Vol. 2. – № 10. – Р. 995-1013.45.Bao, J.J. Molecular evolution of serpins: homologous structure of the humanα1-antichymotrypsin and 1-antitrypsin genes / J.J. Bao, R.N. Sifers, V.J. Kiddet al. // Biochemistry. – 1987. – Vol. 26. – Р.7755-7759.46.Barnes, P.
J. Immunology of asthma and chronic obstructive pulmonary disease/ P. J. Barnes // Nat. Rev. Immunol. – 2008. – Vol. 8. – P.183-192.47.Barnes, P.J. Chronic obstructive pulmonary disease: molecular and cellularmechanisms / P.J. Barnes, S.D. Shapiro, R.A. Pauwels // Eur. Respir. J. – 2003. –Vol. 22. – P. 672-688.48.Bashir, А. Novel variants of SERPIN1A gene: Interplay between alpha1antitrypsin deficiency and chronic obstructive pulmonary disease / А. Bashir,N. N. Shah , Y.
M. Hazariet al. // Respir. Med. – 2016. – Vol. 117. – Р. 139-149.10849.Bathoorn, E. Change in inflammation in out-patient COPD patients from stablephase to a subsequent exacerbation / Е. Bathoorn, J.W. Liesker, D.S. Postma etal. // Int.
J. Chron. Obstruct. Pulmon. Dis. – 2009. – Vol. 4. – Р.101-109.50.Begovich, A.R. Genetic variability and linkage disequilibrium within the HLADP region: analysis of 15 different populations / A.R. Begovich, P.V. Moonsamy,S.J. Mack et al. // Tissue Antigens.
– 2001. – Vol. 57. – P. 424-439.51.Bergdahl, I. А. Increased mortality in COPD among construction workersexposed to in organic dust / I. A. Bergdahl, K. Toren, К. Eriksson et al. // Eur.Respir. J. – 2004. – Vol. 23. – № 3. – Р. 402-406.52.Bergin, D.A. Novel neutrophil derived autoantibodies in alpha-1 antitrypsindeficiency. In: B39. Neutrophils: new insights into their activation andcontribution to lung injury / D.
A. Bergin, К. Hurley, Е. Р. Reeves,N.G. McElvaney // American Thoracic Society International ConferenceAbstracts. American Thoracic Society. – 2013. – P. A2740.53.Bird, Y. Pulmonary effects of active smoking and secondhand smoke exposureamong adolescent students in Juбrez, Mexico / Y.
Bird, H. Staines-Orozco // Int.J. Chron. Obstruct. Pulmon. Dis. – 2016. – Jun. 29. – № 11. – Р. 1459-1467.54.Blanc, P.D. Occupation in chronic obstructive pulmonary disease and chronicbronchitis: an update / P.D. Blanc, K. Torеn // Int. J. Tuberc. Lung Dis. – 2007. –Vol. 11. – № 3. – P. 251-257.55.Bodmer, W.F. Evolution and function of the HLA system / W.F. Bodmer,J.G. Bodmer // Brit. Med. Bull. – 1978. – Vol. 34. – № 3. – P. 309.56.Bose, B.
Transplantation antigens and histocompatibility matching / В. Bose,D.V. Johnson, S.B. Campbell // In: Rath T ed. Current Issues and FutureDirection in Kidney Transplantation. InTech. – 2013. – Р. 371-390.57.Böyum, A. Separation of leucocytes from blood and bone marrow /A. Böyum //Scand. J. Clin. Lab. Invest. – 1968. – Vol. 21. – Suppl.87. – P. 77-82.58.Browning, M. HLA and MHC: genes, molecules and functions / M. Browning,A.
McMichael / Oxford: BIOS Scientific Publishers LTD. – 1996. – Р. 4-25.10959.Burnett, D. Neutrophils from subjects with chronic obstructive lung disease showenhanced chemotaxis and extracellular proteolysis / D. Burnett, A. Chamba,S.L. Hill, R.A. Stockley // Lancet. – 1987. – Vol. 2. – № 8567. – P.1043-1046.60.Byron, K. A.
IL-4 production is increased in cigarette smokers / K.A. Byron,G.A. Varigos, A.M. Wootton // Clin. Exp. Immunol. – 1994. – Vol. 95. – № 2. –P. 333-336.61.Calabrese, F. Marked alveolar apoptosis/proliferation imbalance in end-stageemphysema / F. Calabrese, C. Giacometti, B. Beghe et al. // Respir. Res. – 2005.– № 6. – Р.14.62.Campbell, E. J. Alpha 1 - antitrypsin deficiency: incidence and detection program/ E. J.
Campbell // Respir. Med. – 2000. – V. 94. – Р. 18-21.63.Castranova V. From coal mine dust to quartz: mechanisms of pulmonarypathogenicity / V. Castranova // Inhalation Toxicology. – 2000. – Vol. 12. – № 3.– Р. 7-14.64.Cavicchioni, G. Oligomeric for mylpeptide activity on human neutrophils/ G. Cavicchioni, А. Fraulini, S. Falzarano, S. Spisani // Eur. Med. Chem. – 2009.– Vol.
44. – № 12. – Р. 4926-4930.65.Celli, B.R. Effect of pharmacotherapy on rate of decline of lung function inchronic obstructive pulmonary disease: results from the TORCH study /B.R. Сelli, N.E. Thomas, J.A. Anderson et al. // Am. J. Respir. Crit. Care Med. –2008. – Vol.178. – № 4. – Р. 332-338.66.Chamoto, K. Alveolar macrophage dynamics in murine lung regeneration/ К. Chamoto, B.
C. Gibney, М. Ackermann et al. // J. Cell Physiol. – 2012. –Vol. 227. – Р. 3208-3215.67.Curtis, J.L. The immunopathogenesis of chronic obstructive pulmonary disease:insights from recent research / J.L. Curtis, C.M. Freeman, J.C. Hogg // Proc. Am.Thorac. Soc. – 2007. – Vol. 4. – № 7. – P. 512-521.68.Daffa, N.I. Natural and disease-specific autoantibodies in chronic obstructivepulmonary disease /N.I. Daffa, P.J. Tighe, J.M. Corne et al.
// Clin. Exp.Immunol. – 2015. – Vol.180. – №1. – Р. 155-163.11069.de Marco, R. Risk factors for chronic obstructive pulmonary disease in aEuropean cohort of young adults / R. Marco, S. Accordini, A. Marcon et al. //Am. J. Respir. Crit. Care Med. – 2011. – Vol. 183 – Р. 891-897.70.Di Stefano, A.
Severity of airflow limitation is associated with severity of airwayinflammation in smokers / Di Stefano, A. , Capelli A, Lusuardi M, et al. //. Am. J.Respir. Crit. Care Med. – 1998. – Vol. 158. – № 4. – Р.1277-1285.71.Dorak, M.T. Statistical analysis in HLA and disease association studies/М.Т. Dorak // Available from: http://www.dorak.info. Last updated 27 July2009, last visited at 15 May 2015, at http://www.dorak.info/hla/stat.html.72.Dyer, P. Status report from ‘double agent HLA’: health and disease / Р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
